Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Key Laboratory of Myopia and Related Eye Diseases, NHC; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
Lasers Med Sci. 2024 Oct 7;39(1):250. doi: 10.1007/s10103-024-04200-1.
This study aimed to compare the seven-year refractive outcomes of small incision lenticule extraction (SMILE) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) for correction of myopia and myopic astigmatism. This retrospective cohort study included 97 eyes of 53 patients who had undergone SMILE or FS-LASIK for myopia seven years prior. Measured parameters included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and manifest refraction. There were no significant differences between the SMILE and FS-LASIK groups in logMAR UDVA, cylinder, and logMAR CDVA at 7 years postoperatively (P>0.05). However, there were significant differences between the two groups in sphere and spherical equivalent (P=0.035 and P=0.016, respectively). UDVA was better than or equal to 20/20 in 81% of the eyes after SMILE and in 63% after FS-LASIK (P = 0.045). The efficacy indices of the SMILE and FS-LASIK groups were 1.04 ± 0.23 and 0.97 ± 0.23 (P=0.405), and the safety indices were 1.18 ± 0.19 and 1.10 ± 0.17 (P=0.543), respectively. This study demonstrates the good predictivity of both SMILE and FS-LASIK. SMILE could offer superior refractive outcomes than FS-LASIK during a 7-year follow-up in correcting myopia and myopic astigmatism.
本研究旨在比较小切口微透镜提取术(SMILE)和飞秒激光辅助准分子激光原位角膜磨镶术(FS-LASIK)治疗近视和近视散光的 7 年屈光结果。这是一项回顾性队列研究,纳入了 53 例患者的 97 只眼,这些患者在 7 年前接受了 SMILE 或 FS-LASIK 治疗近视。测量参数包括未矫正远视力(UDVA)、矫正远视力(CDVA)和角膜曲率。术后 7 年,SMILE 组和 FS-LASIK 组的 logMAR UDVA、柱镜和 logMAR CDVA 差异均无统计学意义(P>0.05)。然而,两组在球镜和等效球镜(P=0.035 和 P=0.016)方面存在显著差异。SMILE 组术后 81%的眼 UDVA 优于或等于 20/20,FS-LASIK 组为 63%(P=0.045)。SMILE 组和 FS-LASIK 组的疗效指数分别为 1.04±0.23 和 0.97±0.23(P=0.405),安全性指数分别为 1.18±0.19 和 1.10±0.17(P=0.543)。本研究表明,SMILE 和 FS-LASIK 均具有良好的预测性。在 7 年的随访中,SMILE 在治疗近视和近视散光方面可能提供优于 FS-LASIK 的屈光结果。